Filing Details
- Accession Number:
- 0001209191-13-041574
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-08-20 17:18:26
- Reporting Period:
- 2016-08-16
- Filing Date:
- 2013-08-20
- Accepted Time:
- 2013-08-20 17:18:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1008848 | Acorda Therapeutics Inc | ACOR | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1272354 | Ron Cohen | 420 Saw Mill River Road Ardsley NY 10502 | President And Ceo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-08-16 | 19,000 | $2.60 | 357,090 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2013-08-16 | 42,062 | $2.60 | 399,152 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-08-16 | 61,062 | $34.04 | 338,090 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2013-08-19 | 55,993 | $2.60 | 394,083 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-08-19 | 55,993 | $34.02 | 338,090 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2013-08-20 | 31,945 | $2.60 | 370,035 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-08-20 | 26,105 | $34.25 | 343,930 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-08-20 | 5,840 | $34.82 | 338,090 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2013-08-20 | 19,461 | $2.60 | 357,551 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2013-08-20 | 113,141 | $2.60 | 470,692 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2013-08-20 | 8,176 | $2.60 | 478,868 | No | 4 | M | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2013-08-16 | 19,000 | $0.00 | 19,000 | $2.60 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2013-08-16 | 42,062 | $0.00 | 42,062 | $2.60 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2013-08-19 | 55,993 | $0.00 | 55,993 | $2.60 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2013-08-20 | 31,945 | $0.00 | 31,945 | $2.60 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2013-08-20 | 19,461 | $0.00 | 19,461 | $2.60 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2013-08-20 | 113,141 | $0.00 | 113,141 | $2.60 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2013-08-20 | 8,176 | $0.00 | 8,176 | $2.60 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 19,461 | 2013-10-17 | No | 4 | M | Direct | |
| 201,079 | 2013-09-11 | No | 4 | M | Direct | |
| 145,086 | 2013-09-11 | No | 4 | M | Direct | |
| 113,141 | 2013-09-11 | No | 4 | M | Direct | |
| 0 | 2013-10-17 | No | 4 | M | Direct | |
| 0 | 2013-09-11 | No | 4 | M | Direct | |
| 0 | 2013-09-11 | No | 4 | M | Direct |
Footnotes
- The stock options listed on Table I, Column 4 and Table II, Column 1 are being exercised because all of these options would otherwise expire in September and October of this year.
- A total of 149,000 of the 289,778 shares issued upon exercise of these options have been sold, the proceeds of which are being used to fund the exercise of these options and the resulting tax liability. The sales referred to in Table I, Column 4 were made pursuant to a 10b5-1 plan.
- The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $33.73 to $34.44 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $33.56 to $34.54 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $33.77 to $34.77 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $34.79 to $34.86 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- The shares subject to these options vested in installments and were fully vested on April 17, 2005.
- The shares subject to these options vested in installments and were fully vested on March 31, 2005.
Billionaire Hedge Funds
